Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DelveInsight | PRODUCT CODE: 2082633

Cover Image

PUBLISHER: DelveInsight | PRODUCT CODE: 2082633

Atopic Dermatitis Epidemiology Forecast - 2036

PUBLISHED:
PAGES: 145 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 3990
PDF & Excel (2-3 User License)
USD 4988
PDF & Excel (Site License)
USD 6982
PDF & Excel (Global License)
USD 8977

Add to Cart

Atopic Dermatitis Insights and Trends

  • Atopic dermatitis, also called eczema, is a multifaceted, chronic relapsing inflammatory skin disease commonly associated with other atopic manifestations such as food allergy, allergic rhinitis, and asthma. It is the most common type of skin inflammation that usually starts in early childhood but can occur at any age and can be recurrent or persistent throughout life.
  • According to DelveInsight's estimates, the total prevalent cases of Atopic Dermatitis in the 7MM were approximately 73,243,000 in 2025.
  • Atopic dermatitis is a common condition that usually begins in childhood; however, anyone can get the disease at any age. It has been observed that the prevalence of atopic dermatitis is higher in children than adults across 7MM.
  • The Atopic Dermatitis is found to be more prevalent in females than in males.

Atopic Dermatitis Epidemiology Forecast in the United States

  • 2025 Prevalent Cases of Atopic Dermatitis: ~73,243,000
  • Atopic Dermatitis Growth Rate (2026-2036): 0.4% CAGR

DelveInsight's 'Atopic Dermatitis - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the Atopic Dermatitis, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Atopic Dermatitis Understanding and Diagnosis Algorithm

Atopic Dermatitis Overview

Atopic dermatitis, also called eczema, is a chronic condition and the most common type of skin inflammation that usually starts in early childhood but can occur at any age and can be recurrent or persistent throughout life. In 'dermatitis,' 'derm' means 'skin,' and 'itis' means 'inflammation.' Thus, dermatitis is a skin inflammation characterized by itchiness, redness, and a rash caused by genetics, an overactive immune system, infections, allergies, and irritating substances. Half of the patients with moderate-to-severe eczema also have asthma, hay fever (allergic rhinitis), and food allergies; it is the most common chronic skin disease in children.

Atopic Dermatitis Diagnosis

Atopic dermatitis is diagnosed clinically, as there is no specific laboratory test. Diagnosis is based on characteristic features especially pruritus (essential), chronic or relapsing eczematous lesions, typical distribution patterns (e.g., face/extensor areas in infants, flexural areas in older children and adults), and a personal or family history of atopy along with exclusion of other conditions.

Patients may also present with dry skin, excoriations, papules, and lichenification. Absence of itching should prompt reconsideration of the diagnosis. Atopic Dermatitis must be differentiated from other scaly skin disorders (e.g., seborrheic dermatitis in infants). If treatment fails, alternative diagnoses, including nutritional, metabolic, or immunologic conditions, should be evaluated. Elevated IgE levels are common but are not diagnostic. Skin biopsy and microbiological tests may help rule out other or secondary conditions but are not definitive for Atopic Dermatitis.

Atopic Dermatitis Epidemiology

Key Findings from Atopic Dermatitis Epidemiological Analysis and Forecast

  • According to DelveInsight's estimates, the total prevalent cases of Atopic Dermatitis in the 7MM were approximately 73,243,000 in 2025.
  • It has been observed that the prevalence of atopic dermatitis is higher in children (<18 years); ~35% as compared to adults in the 7MM.
  • In 2025, among severity of atopic dermatitis in the US, mild atopic dermatitis was the most prevalent subtype (~14,739,000 cases), followed by moderate atopic dermatitis.
  • The atopic dermatitis is found to be more prevalent in females than in males.

Scope of the Report:

The report covers a segment of an executive summary, a descriptive overview of Atopic Dermatitis, explaining its causes, signs and symptoms, and pathogenesis.

  • Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

Atopic Dermatitis Patient Population Forecast

Report Key Strengths

  • Epidemiology-based (epi-based) Bottom-up Forecasting
  • 11-year Forecast
  • Patient Burden Trends (by geography)

FAQs:

  • What are the disease risks, burdens, and unmet needs of Atopic Dermatitis? What will be the growth opportunities across the 7MM concerning the patient population with Atopic Dermatitis?
  • What is the historical and forecasted Atopic Dermatitis patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy:

  • Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
  • To understand key opinion leaders' perspectives around the diagnostic challenges to overcome barriers in the future.
  • Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
Product Code: DIEI0256

Table of Contents

1. Key Insights

2. Report Introduction

3. Executive Summary of Atopic Dermatitis

5. Epidemiology Forecast Methodology

4. Atopic Dermatitis Epidemiology Overview at a Glance

  • 4.1. Patient Share (%) Distribution by Country in 2025 in the 7MM
  • 4.2. Patient Share (%) Distribution by Country in 2036 in the 7MM

5. Atopic Dermatitis Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Symptom
  • 5.3. Transmission and Risk Factors
  • 5.4. Pathophysiology
  • 5.5. Diagnosis and Screening
    • 5.5.1. Diagnostic Algorithm
    • 5.5.2. Diagnosis Guidelines

6. Atopic Dermatitis Epidemiology and Patient Population

  • 6.1. Key Findings
  • 6.2. Assumptions and Rationale
  • 6.3. Total Prevalent Cases of Atopic Dermatitis in the 7MM
  • 6.4. The United States
    • 6.4.1. Total Prevalent Cases of Atopic Dermatitis in the US
    • 6.4.2. Total Prevalent Cases of Atopic Dermatitis by Age in the US
    • 6.4.3. Total Diagnosed Prevalent Cases of Atopic Dermatitis in the US
    • 6.4.4. Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the US
    • 6.4.5. Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the US
  • 6.5. EU4 and the UK
    • 6.5.1. Total Prevalent Cases of Atopic Dermatitis in the EU4 and the UK
    • 6.5.2. Total Prevalent Cases of Atopic Dermatitis by Age in the EU4 and the UK
    • 6.5.3. Total Diagnosed Prevalent Cases of Atopic Dermatitis in the EU4 and the UK
    • 6.5.4. Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the EU4 and the UK
    • 6.5.5. Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the EU4 and the UK
  • 6.6. Japan
    • 6.6.1. Total Prevalent Cases of Atopic Dermatitis in the Japan
    • 6.6.2. Total Prevalent Cases of Atopic Dermatitis by Age in the Japan
    • 6.6.3. Total Diagnosed Prevalent Cases of Atopic Dermatitis in the Japan
    • 6.6.4. Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the Japan
    • 6.6.5. Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the Japan

7. Appendix

  • 7.1. Bibliography
  • 7.2. Report Methodology

8. DelveInsight Capabilities

9. Disclaimer

10. About DelveInsight

Product Code: DIEI0256

List of Tables

  • Table 1: Summary of Atopic Dermatitis Epidemiology (2025-2036)
  • Table 2: Atopic Dermatitis Epidemiology
  • Table 3: Total Prevalent Cases of Atopic Dermatitis in the US (2022-2036)
  • Table 4: Total Prevalent Cases of Atopic Dermatitis by Age in the US (2022-2036)
  • Table 5: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the US (2022-2036)
  • Table 6: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the US (2022-2036)
  • Table 7: Total Prevalent Cases of Atopic Dermatitis in the EU4 and the UK (2022-2036)
  • Table 8: Total Prevalent Cases of Atopic Dermatitis by Age in the EU4 and the UK (2022-2036)
  • Table 9: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the EU4 and the UK (2022-2036)
  • Table 10: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the EU4 and the UK (2022-2036)
  • Table 11: Total Prevalent Cases of Atopic Dermatitis in the Japan (2022-2036)
  • Table 12: Total Prevalent Cases of Atopic Dermatitis by Age in the Japan (2022-2036)
  • Table 13: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the Japan (2022-2036)
  • Table 14: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the Japan (2022-2036)

List of Figures

  • Figure 1: Summary of Atopic Dermatitis Epidemiology (2025-2036)
  • Figure 2: Atopic Dermatitis Epidemiology
  • Figure 3: Total Prevalent Cases of Atopic Dermatitis in the US (2022-2036)
  • Figure 4: Total Prevalent Cases of Atopic Dermatitis by Age in the US (2022-2036)
  • Figure 5: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the US (2022-2036)
  • Figure 6: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the US (2022-2036)
  • Figure 7: Total Prevalent Cases of Atopic Dermatitis in the EU4 and the UK (2022-2036)
  • Figure 8: Total Prevalent Cases of Atopic Dermatitis by Age in the EU4 and the UK (2022-2036)
  • Figure 9: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the EU4 and the UK (2022-2036)
  • Figure 10: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the EU4 and the UK (2022-2036)
  • Figure 11: Total Prevalent Cases of Atopic Dermatitis in the Japan (2022-2036)
  • Figure 12: Total Prevalent Cases of Atopic Dermatitis by Age in the Japan (2022-2036)
  • Figure 13: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Severity in the Japan (2022-2036)
  • Figure 14: Total Diagnosed Prevalent Cases of Atopic Dermatitis by Gender in the Japan (2022-2036)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!